Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 1
2013 1
2016 1
2018 2
2019 1
2021 1
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

7 results

Results by year

Filters applied: . Clear all
Page 1
Obesity Affects Endometrial Receptivity by Displacing the Window of Implantation.
Bellver J, Marín C, Lathi RB, Murugappan G, Labarta E, Vidal C, Giles J, Cabanillas S, Marzal A, Galliano D, Ruiz-Alonso M, Simón C, Valbuena D. Bellver J, et al. Reprod Sci. 2021 Nov;28(11):3171-3180. doi: 10.1007/s43032-021-00631-1. Epub 2021 May 25. Reprod Sci. 2021. PMID: 34033112 Clinical Trial.
These women were divided into four groups according to BMI: normal weight (18.5-24.9 kg/m(2); n = 44), overweight (25-29.9 kg/m(2); n = 29), class I obese (30.0-34.9 kg/m(2); n = 54), and class II and III obese (> 35 kg/m(2); n = 43). ...
These women were divided into four groups according to BMI: normal weight (18.5-24.9 kg/m(2); n = 44), overweight (25-29.9 kg/m …
Effect of mifepristone on the transcriptomic signature of endometrial receptivity.
von Grothusen C, Lalitkumar PG, Ruiz-Alonso M, Boggavarapu NR, Navarro R, Miravet-Valenciano J, Gemzell-Danielsson K, Simon C. von Grothusen C, et al. Hum Reprod. 2018 Oct 1;33(10):1889-1897. doi: 10.1093/humrep/dey272. Hum Reprod. 2018. PMID: 30137464
C.S. has a patent gene expression profile (ERA) issued to Igenomix and is scientific director of Igenomix S.L. M.R., R.N. and J.M.V. are employees of Igenomix S.L. TRIAL REGISTRATION NUMBER: N/A....
C.S. has a patent gene expression profile (ERA) issued to Igenomix and is scientific director of Igenomix S.L. M.R., R.N. and J.M …
Quality indicators in radiation oncology: proposal of the Spanish Society of Radiation Oncology (SEOR) for a continuous improvement of the quality of care in oncology.
López Torrecilla J, Marín I Borràs S, Ruiz-Alonso A, Jaen Olasolo J, Vázquez de la Torre ML, Bóveda Carro E, Rodríguez A, Ignacio García E, Caballero Martínez F, Campos Lucas FJ, Lara Jiménez PC, Martínez JC, Ferrer Albiach C. López Torrecilla J, et al. Clin Transl Oncol. 2019 Apr;21(4):519-533. doi: 10.1007/s12094-018-1943-z. Epub 2018 Oct 11. Clin Transl Oncol. 2019. PMID: 30311145 Free article.
The accuracy and reproducibility of the endometrial receptivity array is superior to histology as a diagnostic method for endometrial receptivity.
Díaz-Gimeno P, Ruiz-Alonso M, Blesa D, Bosch N, Martínez-Conejero JA, Alamá P, Garrido N, Pellicer A, Simón C. Díaz-Gimeno P, et al. Fertil Steril. 2013 Feb;99(2):508-17. doi: 10.1016/j.fertnstert.2012.09.046. Epub 2012 Oct 23. Fertil Steril. 2013. PMID: 23102856
PATIENT(S): Eighty-six healthy oocyte donors, regularly cycling, aged 20-34 years with a body mass index (BMI) of 19-25 kg/m(2). INTERVENTION(S): Endometrial biopsies were collected throughout the menstrual cycle. ...
PATIENT(S): Eighty-six healthy oocyte donors, regularly cycling, aged 20-34 years with a body mass index (BMI) of 19-25 kg/m(2). INTE …
Intrauterine human chorionic gonadotropin infusion in oocyte donors promotes endometrial synchrony and induction of early decidual markers for stromal survival: a randomized clinical trial.
Strug MR, Su R, Young JE, Dodds WG, Shavell VI, Díaz-Gimeno P, Ruíz-Alonso M, Simón C, Lessey BA, Leach RE, Fazleabas AT. Strug MR, et al. Hum Reprod. 2016 Jul;31(7):1552-61. doi: 10.1093/humrep/dew080. Epub 2016 Apr 26. Hum Reprod. 2016. PMID: 27122490 Free PMC article. Clinical Trial.
STUDY FUNDING/COMPETING INTERESTS: Funding for this work was provided by NICHD R01 HD042280 (A.T.F.) and NICHD F30 HD082951 (M.R.S.). C.S. and P.D.-G are co-inventors of the patented ERA, which is owned by IGENOMIX SL and was used in this study, and C.S. is a shareholder i …
STUDY FUNDING/COMPETING INTERESTS: Funding for this work was provided by NICHD R01 HD042280 (A.T.F.) and NICHD F30 HD082951 (M.R.S.). …